Is FIGS Stock a Buy After a Big Rally and Richer Valuation?
FIGS' stronger revenue outlook and customer growth support the bull case, but its big rally, richer valuation and cost pressure complicate the buy call.
FIGS' stronger revenue outlook and customer growth support the bull case, but its big rally, richer valuation and cost pressure complicate the buy call.
FIGS shows how healthcare apparel is evolving through essential demand, broader wardrobes, Community Hubs and global growth, despite cost friction.
FIGS' outlook rests on scrubwear strength, rising active customers and a global push, even as tariffs, freight and marketing spending pressure margins.
She's continuing to flag it as a buy. She also feels its price could zoom 63% higher.
FIGS targets a specialized niche within healthcare by selling premium, technically advanced medical apparel directly to professionals. Gildan Activewear maintains a massive global manufacturing footprint to produce high volumes of basic apparel for diverse wholesale and retail markets.
SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced that Trina Spear, Chief Executive Officer and Co-Founder, and Sarah Oughtred, Chief Financial Officer, are scheduled to participate in a fireside chat at the Oppenheimer 26th Annual Consumer Growth and E-Commerce Conference on Tuesday, June 9, 2026, at 12:00 p.m. ET. The audio portion of the fireside chat will b.
Baron Focused Growth Fund had a disappointing start to 2026, with a decline of 4.99% (Institutional Shares) compared with a 3.52% loss for the Russell 2500 Growth Index (the Benchmark). Top contributors were Space Exploration Technologies Corp., FIGS, Inc., and Choice Hotels International, Inc. Top detractors were Tesla, Inc., CoStar Group, Inc., and On Holding AG.
FIGS delivered a standout Q1'26, with 28% revenue growth, 12% active customer growth, and raised full-year revenue and EBITDA guidance. Gross margin expanded despite tariff and freight headwinds, but management models further near-term margin pressure, especially in Q3, before recovery in Q4. International growth (+50% YoY) and demonstrated pricing power highlight multi-year runway, yet marketing spend at 18.4% of revenue raises sustainability concerns.
FIGS NYSE: FIGS reported stronger-than-expected first-quarter fiscal 2026 results, with executives pointing to accelerating customer growth, broad demand across product categories and continued momentum in international markets and physical retail.
Figs beat on sales and beat on earnings last night. Today, it sold off anyway.
FIGS, Inc. (FIGS) Q1 2026 Earnings Call Transcript
Figs (FIGS) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of $0.01 per share. This compares to break-even earnings per share a year ago.
The headline numbers for Figs (FIGS) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS) (the “Company”), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today released its first quarter 2026 financial results and published a financial highlights presentation on its investor relations website at ir.wearfigs.com/financials/quarterly-results/. First Quarter 2026 Financial Highlights Net revenues were $159.9 million, an increase of 28.0% year over year, primarily du.
SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS), the global leading healthcare apparel brand, today announced a long-term partnership with Noah Wyle, Emmy-award winning executive producer and actor. Together, FIGS and Wyle will work to address the most urgent challenges facing the healthcare workforce — including fair compensation, mental health support, workplace safety and administrative burden. The partnership builds on FIGS' advocacy efforts over the past several years, inclu.
FIGS, GAP and CPRI enter the earnings season with strong momentum, margin discipline and positive ESPs, signaling potential earnings surprises.
The consensus price target hints at a 27.1% upside potential for Figs (FIGS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
FIGS eyes 21.9% revenue growth in Q1 2026, driven by strong demand, pricing power and global expansion despite tariff and margin pressures.
SIG's premium mix, pricing power and core brands fuel margin gains, as rising AUR and strong services growth set up fiscal 2027 momentum.
Does Figs (FIGS) have what it takes to be a top stock pick for momentum investors? Let's find out.